Literature DB >> 10917214

Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: a prospective study. IRIS Study Group.

X Carbonell-Estrany1, J Quero, G Bustos, A Cotero, E Doménech, J Figueras-Aloy, J M Fraga, L G García, A García-Alix, M G Del Río, X Krauel, J B Sastre, E Narbona, V Roqués, S S Hernández, M Zapatero.   

Abstract

OBJECTIVE: To collect data on hospitalization for respiratory syncytial virus (RSV) infections and presumptive risk factors for rehospitalization among premature infants in Spain.
DESIGN: Observational, prospective, longitudinal, multicenter study.
SETTING: Fourteen Spanish neonatal units with an annual birth cohort of 57,000 infants. PATIENTS: All children (n = 680) born < or =32 weeks of gestational age between April 1, 1998, and March 31, 1999, and discharged from the hospital before March 31, 1999, were included in the study. A total of 96 were excluded because of administration of prophylactic treatment (n = 55) or were lost to follow-up (n = 41). Five children died during the study period, but death was related to RSV in only 1 case. METHODS AND MAIN OUTCOME MEASURES: Neonatal and demographic data were recorded at the initial visit. Infants were prospectively followed at monthly intervals up to March 31, 1999. In patients rehospitalized for respiratory disorders, further data about RSV status and morbidity were collected. A comparison was made between children rehospitalized for RSV infection and those who were not. The influence of factors on the probability of rehospitalization for RSV infection was assessed by logistic regression analysis.
RESULTS: Of the 584 evaluable patients 118 (20.2%) were rehospitalized for respiratory disease during the study period. The causative pathogen was identified in 89 (75.4%) hospital admissions. Of these 59 (66.3%) were a result of RSV infection in 53 children; 6 were reinfections. In a logistic regression model significant independent prognostic variables included: lower risk of RSV hospitalization with increase gestational age [odds ratio (OR), 0.85; 95% confidence interval (CI), 0.72 to 0.99; P < 0.047]; higher risk with chronic lung disease (OR = 3.1; 95% CI 1.22 to 7.91; P < 0.016); and living with school age siblings (OR = 1.86; 95% CI 1.01 to 3.4; P < 0.048).
CONCLUSION: This large descriptive study has enabled us to define the influence of specific risk factors that increase the risk of rehospitalization for RSV infection in preterm infants. Such studies help to define the appropriate role of available prophylactic interventions and establish treatment guidelines.

Entities:  

Mesh:

Year:  2000        PMID: 10917214     DOI: 10.1097/00006454-200007000-00002

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  39 in total

Review 1.  Respiratory morbidity and lung function in preterm infants of 32 to 36 weeks' gestational age.

Authors:  Andrew A Colin; Cynthia McEvoy; Robert G Castile
Journal:  Pediatrics       Date:  2010-06-07       Impact factor: 7.124

2.  Prolonged exclusive breastfeeding, autumn birth and increased gestational age are associated with lower risk of fever in children with hand, foot, and mouth disease.

Authors:  Q Zhu; Y Li; N Li; Q Han; Z Liu; Z Li; J Qiu; G Zhang; F Li; N Tian
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-01-26       Impact factor: 3.267

3.  Scope and impact of early and late preterm infants admitted to the PICU with respiratory illness.

Authors:  Cameron F Gunville; Marci K Sontag; Kristin A Stratton; Daksha J Ranade; Steven H Abman; Peter M Mourani
Journal:  J Pediatr       Date:  2010-03-24       Impact factor: 4.406

4.  Net cost of palivizumab for respiratory syncytial virus prophylaxis during the 1998/99 season in northern Alberta.

Authors:  S L Lee; P Etches; J L Robinson
Journal:  Paediatr Child Health       Date:  2001-10       Impact factor: 2.253

5.  Preterm cord blood CD4⁺ T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4⁺ T cells in bronchopulmonary dysplasia.

Authors:  Ravi Misra; Syed Shah; Deborah Fowell; Hongyue Wang; Kristin Scheible; Sara Misra; Heidie Huyck; Claire Wyman; Rita M Ryan; Anne Marie Reynolds; Tom Mariani; Philip J Katzman; Gloria S Pryhuber
Journal:  Hum Immunol       Date:  2015-03-20       Impact factor: 2.850

6.  At-risk characteristics for hospital admissions and ED visits.

Authors:  Shannon M Hudson; Martina Mueller; William H Hester; Gayenell S Magwood; Susan D Newman; Marilyn A Laken
Journal:  J Spec Pediatr Nurs       Date:  2014-03-03       Impact factor: 1.260

7.  Effects of a transition home program on preterm infant emergency room visits within 90 days of discharge.

Authors:  B Vohr; E McGowan; L Keszler; M O'Donnell; K Hawes; R Tucker
Journal:  J Perinatol       Date:  2017-09-14       Impact factor: 2.521

8.  A Review of the CD4+ T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population.

Authors:  Ravi S Misra
Journal:  EC Microbiol       Date:  2014

9.  Palivizumab: a review of its use in the protection of high risk infants against respiratory syncytial virus (RSV).

Authors:  Joseph M Geskey; Neal J Thomas; Gretchen L Brummel
Journal:  Biologics       Date:  2007-03

10.  Cost effectiveness of palivizumab in Spain: an analysis using observational data.

Authors:  Mark J Nuijten; Wolfgang Wittenberg
Journal:  Eur J Health Econ       Date:  2009-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.